Skip to content

Clinical trials

Phase 4 Bipolar Disorder trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bipolar Disorder Phase: Phase 4 Country / region: Canada Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20031
20041
20051
20061
20071
20091
20111
20141

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Queen's University2
Eli Lilly and Company1
McGill University Health Centre/Research Institute of the McGill University Health Centre1
Nova Scotia Health Authority1
Novartis1
St. Joseph's Healthcare Hamilton1
University Health Network, Toronto1
University of Saskatchewan1
Weill Medical College of Cornell University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bipolar Disorder10
Depressive Disorder2
Mania2
Major Depressive Disorder1
Psychotic Disorders1
Schizophrenia1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.